The Use of Research Abstracts in Formulary Decision Making by the Joint Oncology Drug Review of Canada

ISSN： 1175-5652

Source： Applied Health Economics and Health Policy, Vol.8, Iss.6, 2010-11, pp. : 387-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Drug Treatment of GERD: Economic Issues for Formulary Decision Makers

By James Chan

Disease Management & Health Outcomes, Vol. 12, Iss. 6, 2004-01 ,pp. : 399-407

Adis International

Access to resources Recommend Favorite

Research into the use of health economics in decision making in the United Kingdom-Phase II - Is health economics 'for good or evil'?

By Duthie T. Trueman P. Chancellor J. Diez L.

Health Policy, Vol. 46, Iss. 2, 1999-01 ,pp. : 143-157

Elsevier

Access to resources Recommend Favorite

Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers

By Chock A. Gong V. Destache C.J.

Disease Management & Health Outcomes, Vol. 10, Iss. 6, 2002-01 ,pp. : 333-336

Adis International

Access to resources Recommend Favorite

Centralising Drug Review to Improve Coverage Decisions: Economic Lessons From (and For) Canada

By Morgan Steve

Applied Health Economics and Health Policy, Vol. 5, Iss. 2, 2006-01 ,pp. : 67-73

Adis International

Access to resources Recommend Favorite

Priority setting in a hospital drug formulary: a qualitative case study and evaluation

By Martin D.K. Hollenberg D. MacRae S. Madden S. Singer P.

Health Policy, Vol. 66, Iss. 3, 2003-12 ,pp. : 295-303

Elsevier

Access to resources Recommend Favorite